Boris Galjartمشاهده پروفایل
پژوهشگر
Boris Galjart is a researcher at Erasmus MC, affiliated with the Department of Surgery within the Faculty of Medicine. His work is centered on surgical oncology, particularly in the context of colorectal liver metastases and patient survival outcomes. His primary research interests include: Colorectal Liver Metastasis Histopathological Growth Patterns Survival Analysis and Oncological Outcomes Follow-up Strategies in Cancer Circulating Tumor DNA Ablation Therapies The analysis of his recent publications reveals a strong focus on clinical and translational research in gastrointestinal oncology. His work frequently involves meta-analyses, cohort studies, and evaluation of therapeutic interventions such as hepatic arterial infusion chemotherapy and thermal ablation. There is a consistent theme of assessing prognostic factors and treatment efficacy in colorectal cancer patients with liver metastases. His scientific contributions include a significant meta-analysis on follow-up strategies across common cancers and studies evaluating the impact of histopathological features on treatment outcomes. These works have been published in reputable journals such as European Journal of Cancer and Annals of Surgical Oncology . Boris Galjart actively collaborates with leading researchers in surgical oncology and participates in multidisciplinary studies involving radiology, pathology, and molecular diagnostics. He has contributed to the MIRACLE study and other clinical initiatives aimed at improving cancer care through evidence-based follow-up and innovative biomarker use.





